Nanologica AB (publ)
Climate Impact & Sustainability Data (2022)
Reporting Period: 2022
Environmental Metrics
ESG Focus Areas
- Sustainability
- Employee well-being
- Diversity & Inclusion
Environmental Achievements
- Improved resource efficiency in silica production through more efficient purification processes, reducing the amount of solvents needed in the production of peptide drugs.
Social Achievements
- Increased the health benefits for all employees.
- Implemented a whistleblower policy and function to increase safety and ensure independence within the company.
- Featured on Allbright's green list for the percentage of women in leading positions.
Governance Achievements
- Established a framework for the company's sustainability work.
- Implemented a Code of Conduct to promote ethical principles and responsible business practices.
- Implemented a whistleblower policy and function.
Climate Goals & Targets
Medium-term Goals:
- Achieve sales exceeding 100 MSEK in preparative chromatography by 2024.
Short-term Goals:
- Achieve a commercial breakthrough in 2023.
Environmental Challenges
- Supply chain disruptions due to raw material and component shortages, and manufacturing equipment malfunctions.
- High energy prices and inflation.
- Travel restrictions in China due to COVID-19.
Mitigation Strategies
- Mitigated risks and uncertainties related to global instability.
- Production largely pre-paid, minimizing impact of high energy prices and inflation.
- Travel restrictions in China lifted in early 2023.
Climate-Related Risks & Opportunities
Physical Risks
- Extreme weather events impacting raw material availability and energy prices.
Transition Risks
- Changes in legislation, demand for products and services, and customer behavior related to climate neutrality.
Opportunities
- Development of energy-efficient products and processes.
Reporting Standards
Frameworks Used: IFRS
Certifications: GMP
Third-party Assurance: BDO Mälardalen AB
UN Sustainable Development Goals
- Goal 3: Good Health and Well-being
- Goal 9: Industry, Innovation and Infrastructure
- Goal 12: Responsible Consumption and Production
Nanologica's work contributes to these goals by increasing access to affordable and effective medicines, promoting sustainable manufacturing processes, and fostering innovation in drug delivery.
Sustainable Products & Innovation
- NLAB Saga® (preparative chromatography)
- NAP™ (drug delivery platform)
Awards & Recognition
- Allbright's green list